205 related articles for article (PubMed ID: 8080392)
1. Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data.
Fillenbaum GG; Wilkinson WE; Welsh KA; Mohs RC
Arch Neurol; 1994 Sep; 51(9):916-21. PubMed ID: 8080392
[TBL] [Abstract][Full Text] [Related]
2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
3. Designing a Brief Alzheimer Screen (BAS).
Mendiondo MS; Ashford JW; Kryscio RJ; Schmitt FA
J Alzheimers Dis; 2003 Oct; 5(5):391-8. PubMed ID: 14646030
[TBL] [Abstract][Full Text] [Related]
4. Validity of a semantically cued recall procedure for the mini-mental state examination.
Yuspeh RL; Vanderploeg RD; Kershaw DA
Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):207-11. PubMed ID: 9845412
[TBL] [Abstract][Full Text] [Related]
5. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
6. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
[TBL] [Abstract][Full Text] [Related]
7. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
[TBL] [Abstract][Full Text] [Related]
8. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
9. The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
Nerg O; Junkkari A; Hallikainen I; Rauramaa T; Luikku A; Hiltunen M; Jääskeläinen JE; Leinonen V; Hänninen T; Koivisto A
J Alzheimers Dis; 2021; 81(3):1117-1130. PubMed ID: 33896842
[TBL] [Abstract][Full Text] [Related]
10. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
Clark CM; Ewbank D; Lerner A; Doody R; Henderson VW; Panisset M; Morris JC; Fillenbaum GG; Heyman A
Neurology; 1997 Jul; 49(1):70-5. PubMed ID: 9222172
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological assessment of Alzheimer's disease: the experience of the Consortium to Establish a Registry for Alzheimer's Disease.
Mirra SS
Int Psychogeriatr; 1997; 9 Suppl 1():263-8; discussion 269-72. PubMed ID: 9447447
[TBL] [Abstract][Full Text] [Related]
13. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
Wattmo C; Minthon L; Wallin ÅK
Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
[TBL] [Abstract][Full Text] [Related]
15. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease.
Galasko D; Klauber MR; Hofstetter CR; Salmon DP; Lasker B; Thal LJ
Arch Neurol; 1990 Jan; 47(1):49-52. PubMed ID: 2294894
[TBL] [Abstract][Full Text] [Related]
16. Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease.
Maurano STP; da Silva DJ; Ávila MP; Magacho L
Int Ophthalmol; 2018 Oct; 38(5):1839-1844. PubMed ID: 28744790
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer patient evaluation and the mini-mental state: item characteristic curve analysis.
Ashford JW; Kolm P; Colliver JA; Bekian C; Hsu LN
J Gerontol; 1989 Sep; 44(5):P139-46. PubMed ID: 2768772
[TBL] [Abstract][Full Text] [Related]
19. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment?
Cacho J; Benito-León J; García-García R; Fernández-Calvo B; Vicente-Villardón JL; Mitchell AJ
J Alzheimers Dis; 2010; 22(3):889-96. PubMed ID: 20858951
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer's disease.
Heinik J; Kavé G
Int Psychogeriatr; 2015 May; 27(5):785-91. PubMed ID: 25597552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
